Negotiating Medicare Drug Prices: A New Attempt to Control Purchase Prices
Journal of Law, Medicine & Ethics · 2025 · 53 (1) · 147-157
DOI: 10.1017/jme.2025.59 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law, Medicine & Ethics, online erschienen am 21.04.2025. Verfasst von Marc A Rodwin. Beteiligte Einrichtung: School of Law, Suffolk University, Boston, United States. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The Inflation Reduction Act (IRA) creates a new process to cap Medicare Part D branded drug prices. It prohibits Medicare from paying more than a specified discount from average private market prices and requires that CMS negotiate with manufacturers to agree on a maximum fair price that Medicare will pay that is lower than the specified discount. This article analyzes the cause of high drug prices and how negotiations to set the maximum fair price might unfold. It compares Medicare’s new pricing process to the way drug prices are set in Medicaid, the Veterans Administration, U.S. private insurers, and European nations. It analyzes how negotiations to set the maximum fair price might unfold in light of negotiation theory and the practices to negotiate prices employed in Europe. It draws inferences from the initial published data on the first round of negotiated prices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Law, Suffolk University, Boston, United States.
ORCID-Profile: Marc A Rodwin
Zitieren
APA
Rodwin, M. A. (2025). Negotiating Medicare Drug Prices: A New Attempt to Control Purchase Prices. Journal of Law, Medicine & Ethics, 53(1), 147-157. https://doi.org/10.1017/jme.2025.59
Vancouver
Rodwin MA. Negotiating Medicare Drug Prices: A New Attempt to Control Purchase Prices. Journal of Law, Medicine & Ethics. 2025;53(1):147-157. doi:10.1017/jme.2025.59
BibTeX
@article{Rodwin2025,
author = {Rodwin, Marc A},
title = {Negotiating Medicare Drug Prices: A New Attempt to Control Purchase Prices},
journal = {Journal of Law, Medicine & Ethics},
year = {2025},
volume = {53},
number = {1},
pages = {147--157},
doi = {10.1017/jme.2025.59}
}
EUVIMED